Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study

Eric Morand; Vera Golder; Rangi Kandane-Rathnayake; Molla Huq; Hieu Nim; Worawit Louthrenoo; Shue Fen Luo; Aisha Lateef; Sargunan Sockalingam; Sandra Navarra; Laniyati Hamijoyo; Yasuhiro  Katsumata; Madelynn Chan; Alberta Hoi; Mandana Nikpour

Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study

Eric Morand
, Vera Golder
, Rangi Kandane-Rathnayake
, Molla Huq
, Hieu Nim
, Worawit Louthrenoo
, Shue Fen Luo
, Aisha Lateef
, Sargunan Sockalingam
, Sandra Navarra
, Laniyati Hamijoyo
, Yasuhiro Katsumata
, Madelynn Chan
, Alberta Hoi
, Mandana Nikpour

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Number of pages	1
Publication status	Published - 2019
Event	International Congress on Systemic Lupus Erythematosus 2019 - San Francisco, United States of America Duration: 5 Apr 2019 → 8 Apr 2019 Conference number: 13th https://lupus.bmj.com/content/6/Suppl_1

Conference

Conference	International Congress on Systemic Lupus Erythematosus 2019
Abbreviated title	LUPUS 2019
Country/Territory	United States of America
City	San Francisco
Period	5/04/19 → 8/04/19
Internet address	https://lupus.bmj.com/content/6/Suppl_1

Cite this

Morand, E., Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Lateef, A., Sockalingam, S., Navarra, S., Hamijoyo, L., Katsumata, Y., Chan, M., Hoi, A., & Nikpour, M. (2019). Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study. Abstract from International Congress on Systemic Lupus Erythematosus 2019, San Francisco, California, United States of America.

@conference{c32e1e9520174305806c2e3be0fcacf9,

title = "Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study",

author = "Eric Morand and Vera Golder and Rangi Kandane-Rathnayake and Molla Huq and Hieu Nim and Worawit Louthrenoo and Luo, \{Shue Fen\} and Aisha Lateef and Sargunan Sockalingam and Sandra Navarra and Laniyati Hamijoyo and Yasuhiro Katsumata and Madelynn Chan and Alberta Hoi and Mandana Nikpour",

year = "2019",

language = "English",

note = "International Congress on Systemic Lupus Erythematosus 2019, LUPUS 2019 ; Conference date: 05-04-2019 Through 08-04-2019",

url = "https://lupus.bmj.com/content/6/Suppl\_1",

}

Morand, E , Golder, V , Kandane-Rathnayake, R, Huq, M, Nim, H, Louthrenoo, W, Luo, SF, Lateef, A, Sockalingam, S, Navarra, S, Hamijoyo, L, Katsumata, Y, Chan, M, Hoi, A & Nikpour, M 2019, 'Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study', International Congress on Systemic Lupus Erythematosus 2019, San Francisco, United States of America, 5/04/19 - 8/04/19.

Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study. / Morand, Eric ; Golder, Vera ; Kandane-Rathnayake, Rangi et al.
2019. Abstract from International Congress on Systemic Lupus Erythematosus 2019, San Francisco, California, United States of America.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study

AU - Morand, Eric

AU - Golder, Vera

AU - Kandane-Rathnayake, Rangi

AU - Huq, Molla

AU - Nim, Hieu

AU - Louthrenoo, Worawit

AU - Luo, Shue Fen

AU - Lateef, Aisha

AU - Sockalingam, Sargunan

AU - Navarra, Sandra

AU - Hamijoyo, Laniyati

AU - Katsumata, Yasuhiro

AU - Chan, Madelynn

AU - Hoi, Alberta

AU - Nikpour, Mandana

N1 - Conference code: 13th

PY - 2019

Y1 - 2019

M3 - Abstract

T2 - International Congress on Systemic Lupus Erythematosus 2019

Y2 - 5 April 2019 through 8 April 2019

ER -